- JAMA Oncology Peer Reviewers in 2025
- Survival Without Adjuvant Therapy for Low-Risk Endometrial Cancer With Isolated Tumor Cells
- The Next Frontier for Transparency in Cancer Randomized Clinical Trials
- The Vocabulary of Survival
- The Good Cancer, the Barely Cancer, and the Incurable Cancer
- Insurance Barriers to Next-Generation Sequencing Testing in Lung Cancer
- JAMA Oncology
- Obesity Control’s Underestimated Potential for Cancer Prevention
- Genomic Therapy Matching in Rare and Refractory Cancers
- Person-Centered Care in Geriatric Oncology—Understanding What Matters Most
- Delivering Precision Oncology at Scale—Infrastructure, Evidence, and the Path Forward
- JAMA Oncology —The Year in Review, 2025
- Outcomes of Older Adults With Advanced Cancer Who Prefer Quality of Life vs Prolonging Survival
- Upadacitinib for Immune Checkpoint Inhibitor–Related Dermatitis
- Cancer Risk in Solid Organ Transplant Recipients With a Pretransplant Cancer History
